These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9056061)

  • 21. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantage of high-surface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model.
    Roberts JR; Gracely EJ; Schoffstall JM
    Acad Emerg Med; 1997 Mar; 4(3):167-74. PubMed ID: 9063541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration.
    Laine K; Kivistö KT; Pelttari S; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):270-3. PubMed ID: 8936562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed peak serum valproic acid in massive divalproex overdose--treatment with charcoal hemoperfusion.
    Graudins A; Aaron CK
    J Toxicol Clin Toxicol; 1996; 34(3):335-41. PubMed ID: 8667473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cholestyramine resin on single dose valproate pharmacokinetics.
    Malloy MJ; Ravis WR; Pennell AT; Diskin CJ
    Int J Clin Pharmacol Ther; 1996 May; 34(5):208-11. PubMed ID: 8738857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of phenytoin elimination by multiple-dose activated charcoal.
    Mauro LS; Mauro VF; Brown DL; Somani P
    Ann Emerg Med; 1987 Oct; 16(10):1132-5. PubMed ID: 3662159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid.
    el-Bahie N; Allen EM; Williams J; Routledge PA
    Br J Clin Pharmacol; 1985 Jun; 19(6):836-8. PubMed ID: 4027125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anticholinergic drugs on the efficacy of activated charcoal.
    Green R; Sitar DS; Tenenbein M
    J Toxicol Clin Toxicol; 2004; 42(3):267-72. PubMed ID: 15362593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.
    Orisakwe OE; Ilondu NA; Afonne OJ; Ofoefule SI; Orish CN
    Pharmacol Res; 2000 Aug; 42(2):167-70. PubMed ID: 10887047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of kinetic interaction between valproic acid and citrus pectin.
    Issy AM; Lanchote VL; de Carvalho D; Silva HC
    Ther Drug Monit; 1997 Oct; 19(5):516-20. PubMed ID: 9357093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
    Gude AB; Hoegberg LC; Angelo HR; Christensen HR
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate.
    Galinsky RE; Levy G
    J Toxicol Clin Toxicol; 1984 Jul; 22(1):21-30. PubMed ID: 6492228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy.
    Chyka PA; Holley JE; Mandrell TD; Sugathan P
    Ann Emerg Med; 1995 Mar; 25(3):356-62. PubMed ID: 7864477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reply to Multiple-dose activated charcoal in carbamazepine poisoning.
    Brahmi N
    Am J Emerg Med; 2007 May; 25(4):485. PubMed ID: 17499676
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of Activated Charcoal on Rivaroxaban Complex Absorption.
    Ollier E; Hodin S; Lanoiselée J; Escal J; Accassat S; De Magalhaes E; Basset T; Bertoletti L; Mismetti P; Delavenne X
    Clin Pharmacokinet; 2017 Jul; 56(7):793-801. PubMed ID: 27910037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
    Laine K; Kivistö KT; Laakso I; Neuvonen PJ
    Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of purgatives on antidotal efficacy of oral activated charcoal.
    Neuvonen PJ; Olkkola KT
    Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of urine alkalization and activated charcoal on the pharmacokinetics of orally administered carprofen in dogs.
    Raekallio MR; Honkavaara JM; Säkkinen MS; Peltoniemi SM
    Am J Vet Res; 2007 Apr; 68(4):423-7. PubMed ID: 17397299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.